πŸ‡ΊπŸ‡Έ FDA
Patent

US 7410956

Caspase inhibitor prodrugs

granted A61PA61P35/04A61P37/06

Quick answer

US patent 7410956 (Caspase inhibitor prodrugs) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/04, A61P37/06, A61P9/00